CCRN
Cross Country Healthcare, Inc. NASDAQ Listed Oct 25, 2001$13.07
Mkt Cap $422.4M
52w Low $7.43
74.6% of range
52w High $14.99
50d MA $9.65
200d MA $10.81
P/E (TTM)
-3.5x
EV/EBITDA
11.7x
P/B
1.0x
Debt/Equity
0.0x
ROE
-25.7%
P/FCF
6.5x
RSI (14)
—
ATR (14)
—
Beta
0.34
50d MA
$9.65
200d MA
$10.81
Avg Volume
467.5K
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
6551 Park of Commerce Boulevard, N.W. · Boca Raton, FL 33487 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.05 | -0.03 | +40.0% | 13.09 | -0.2% | +0.7% | — | — | — | — | — |
| Mar 4, 2026 | AMC | 0.03 | -0.06 | -300.0% | 9.13 | -2.0% | +8.3% | +7.6% | +10.2% | +7.9% | +7.1% | — |
| Nov 12, 2025 | AMC | 0.04 | 0.03 | -25.0% | 12.65 | -13.4% | -14.1% | -12.0% | -8.0% | -7.2% | -8.8% | — |
| Aug 6, 2025 | AMC | 0.07 | -0.01 | -114.3% | 13.10 | -2.7% | -4.4% | -2.9% | -3.3% | -2.6% | +0.1% | — |
| May 7, 2025 | AMC | 0.04 | 0.06 | +50.0% | 13.84 | -2.5% | +0.4% | +1.2% | +0.6% | +0.8% | +1.1% | — |
| Mar 5, 2025 | AMC | 0.11 | 0.04 | -63.6% | 16.86 | -0.3% | -6.3% | -5.5% | -6.0% | -6.0% | -5.8% | — |
| Nov 6, 2024 | AMC | 0.10 | 0.12 | +20.0% | 12.15 | +0.2% | +1.0% | -14.7% | -11.5% | -9.2% | -16.9% | — |
| Jul 31, 2024 | AMC | 0.14 | 0.10 | -28.6% | 18.24 | -5.0% | -3.8% | -6.2% | -9.2% | -8.9% | -13.7% | — |
| May 1, 2024 | AMC | 0.17 | 0.19 | +11.8% | 17.90 | -9.9% | -6.5% | -6.9% | -10.5% | -8.2% | -8.0% | — |
| Feb 21, 2024 | AMC | 0.27 | 0.29 | +7.4% | 17.02 | -4.4% | -0.2% | -0.1% | +2.3% | +7.2% | +9.9% | — |
| Nov 1, 2023 | AMC | 0.41 | 0.39 | -4.9% | 23.09 | -30.2% | -13.8% | -16.1% | -18.7% | -20.2% | -19.4% | — |
| Aug 2, 2023 | AMC | 0.61 | 0.69 | +13.1% | 26.50 | -18.3% | -17.0% | -19.2% | -16.3% | -14.3% | -12.2% | — |
| May 3, 2023 | AMC | 0.75 | 0.84 | +12.0% | 21.44 | -4.3% | +4.8% | +9.6% | +9.6% | +15.1% | +13.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 | Wedbush | Upgrade | Neutral → Outperform | — | $8.86 | $9.31 | +5.1% | +5.5% | +3.6% | +8.0% | +10.0% | +10.5% |
| Mar 5 | Benchmark | Upgrade | Hold → Buy | — | $9.13 | $8.95 | -2.0% | +8.3% | +7.6% | +10.2% | +7.9% | +7.1% |
| Dec 9 | UBS | Maintains | Neutral → Neutral | — | $8.14 | $8.17 | +0.4% | -2.3% | +0.2% | +5.8% | +4.3% | +1.4% |
| Jun 17 | Barrington Research | Maintains | Market Perform → Market Perform | — | $13.79 | $13.68 | -0.8% | +1.2% | +3.3% | +1.7% | -3.6% | -4.6% |
| May 13 | UBS | Maintains | Neutral → Neutral | — | $13.92 | $13.92 | +0.0% | +0.2% | +0.5% | +0.2% | +0.5% | +0.1% |
| Mar 14 | Barrington Research | Maintains | Market Perform → Market Perform | — | $15.76 | $15.78 | +0.1% | -1.1% | -2.8% | -5.5% | -5.2% | -6.1% |
| Feb 6 | JMP Securities | Maintains | Market Perform → Market Perform | — | $18.22 | $18.21 | -0.1% | -0.1% | -0.2% | -0.1% | +0.1% | +0.1% |
| Dec 10 | Barrington Research | Downgrade | Outperform → Market Perform | — | $18.06 | $18.06 | +0.0% | +0.1% | -0.1% | +0.0% | +0.0% | -0.7% |
| Dec 5 | Truist | Maintains | Hold → Hold | — | $18.16 | $18.15 | -0.1% | -0.5% | -0.4% | -0.6% | -0.5% | -0.7% |
| Nov 7 | Benchmark | Maintains | Buy → Buy | — | $12.15 | $12.18 | +0.2% | +1.0% | -14.7% | -11.5% | -9.2% | -16.9% |
| Oct 21 | Truist | Maintains | Hold → Hold | — | $12.87 | $12.74 | -1.0% | -6.6% | -6.8% | -8.0% | -8.2% | -10.1% |
| Aug 8 | Barrington Research | Maintains | Outperform → Outperform | — | $15.74 | $15.93 | +1.2% | -0.4% | -2.9% | -9.1% | -8.3% | -10.3% |
| Aug 1 | Truist | Maintains | Hold → Hold | — | $18.24 | $17.32 | -5.0% | -3.8% | -6.2% | -9.2% | -8.9% | -13.7% |
| May 6 | Barrington Research | Maintains | Outperform → Outperform | — | $16.67 | $16.95 | +1.7% | -3.9% | -1.4% | -1.2% | -1.6% | -10.4% |
| May 2 | Benchmark | Maintains | Buy → Buy | — | $17.90 | $16.12 | -9.9% | -6.5% | -6.9% | -10.5% | -8.2% | -8.0% |
| Feb 27 | Barrington Research | Maintains | Outperform → Outperform | — | $17.41 | $17.49 | +0.5% | +4.8% | +7.4% | +4.9% | +5.8% | +6.5% |
| Feb 22 | Truist | Maintains | Hold → Hold | — | $17.02 | $16.27 | -4.4% | -0.2% | -0.1% | +2.3% | +7.2% | +9.9% |
| Feb 22 | Benchmark | Maintains | Buy → Buy | — | $17.02 | $16.27 | -4.4% | -0.2% | -0.1% | +2.3% | +7.2% | +9.9% |
| Nov 29 | Barrington Research | Maintains | Outperform → Outperform | — | $20.72 | $20.89 | +0.8% | -1.5% | -2.2% | -0.2% | +6.4% | +1.4% |
| Nov 3 | Truist | Maintains | Hold → Hold | — | $19.91 | $19.76 | -0.8% | -2.7% | -5.7% | -7.5% | -6.5% | -8.8% |
| Nov 3 | Jefferies | Downgrade | Buy → Hold | — | $19.91 | $19.76 | -0.8% | -2.7% | -5.7% | -7.5% | -6.5% | -8.8% |
| Oct 5 | Jefferies | Maintains | Buy → Buy | — | $25.55 | $25.36 | -0.7% | -3.0% | -7.6% | -4.3% | -6.8% | -8.6% |
| Aug 14 | Barrington Research | Maintains | Outperform → Outperform | — | $23.01 | $23.02 | +0.0% | +2.4% | +5.6% | +2.8% | +4.7% | +8.4% |
| Aug 8 | Credit Suisse | Maintains | Neutral → Neutral | — | $22.19 | $22.14 | -0.2% | +2.4% | +4.8% | +4.4% | +3.7% | +6.2% |
| Jun 1 | Barrington Research | Maintains | Outperform → Outperform | — | $25.50 | $25.47 | -0.1% | +1.2% | +5.7% | +2.8% | +5.0% | +7.4% |
| May 5 | Credit Suisse | Maintains | Neutral → Neutral | — | $22.46 | $22.79 | +1.5% | +4.6% | +4.6% | +9.9% | +8.1% | +9.7% |
| May 2 | Truist | Maintains | Hold → Hold | — | $22.45 | $22.07 | -1.7% | -4.8% | -4.5% | +0.0% | +4.7% | +4.7% |
| Feb 23 | Benchmark | Maintains | Buy → Buy | — | $26.51 | $25.02 | -5.6% | -6.4% | -1.8% | +2.3% | -0.2% | +0.5% |
| Feb 23 | Credit Suisse | Maintains | Neutral → Neutral | — | $26.51 | $25.02 | -5.6% | -6.4% | -1.8% | +2.3% | -0.2% | +0.5% |
| Nov 7 | Barrington Research | Maintains | Outperform → Outperform | — | $32.50 | $32.05 | -1.4% | +2.9% | +4.6% | +2.3% | +2.1% | -6.0% |
| Oct 5 | Truist | Downgrade | Buy → Hold | — | $33.59 | $32.16 | -4.3% | -6.0% | -8.3% | -6.0% | -4.0% | -3.7% |
| Sep 15 | Benchmark | Maintains | Buy → Buy | — | $28.75 | $29.25 | +1.7% | +1.9% | +3.0% | +3.0% | +2.9% | +1.0% |
| Jun 13 | Benchmark | Maintains | Buy → Buy | — | $18.48 | $17.76 | -3.9% | -4.9% | -2.2% | +6.3% | -3.5% | +3.3% |
| Jun 9 | Credit Suisse | Maintains | Neutral → Neutral | — | $18.21 | $18.04 | -0.9% | +2.1% | +1.5% | -3.5% | -0.8% | +7.9% |
| Feb 24 | Benchmark | Maintains | Buy → Buy | — | $21.00 | $20.87 | -0.6% | -1.8% | +11.6% | +6.3% | +1.9% | +6.1% |
| Jan 27 | Jefferies | Upgrade | Hold → Buy | — | $17.92 | $19.33 | +7.9% | +7.3% | +12.5% | +20.0% | +22.7% | +23.7% |
| Aug 16 | Credit Suisse | Maintains | Neutral → Neutral | — | $18.73 | $18.16 | -3.1% | +8.2% | +6.6% | +4.5% | +1.0% | +6.9% |
| Aug 5 | Benchmark | Upgrade | Hold → Buy | — | $16.44 | $18.00 | +9.5% | +24.7% | +17.0% | +16.2% | +18.1% | +17.1% |
| May 6 | Benchmark | Downgrade | Buy → Hold | — | $14.19 | $14.58 | +2.7% | +13.5% | +19.1% | +20.9% | +17.2% | +11.3% |
| May 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $14.19 | $14.58 | +2.7% | +13.5% | +19.1% | +20.9% | +17.2% | +11.3% |
| Feb 25 | Credit Suisse | Maintains | Neutral → Neutral | — | $10.06 | $11.29 | +12.2% | +12.5% | +10.4% | +17.9% | +12.2% | +17.1% |
| Nov 23 | BMO Capital | Upgrade | Market Perform → Outperform | — | $7.72 | $8.24 | +6.7% | +6.3% | +15.9% | +20.7% | +21.6% | +12.7% |
| Nov 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $7.85 | $9.32 | +18.7% | +0.0% | -6.4% | +2.0% | +3.8% | -2.0% |
| Nov 5 | Credit Suisse | Maintains | Neutral → Neutral | — | $7.85 | $9.32 | +18.7% | +0.0% | -6.4% | +2.0% | +3.8% | -2.0% |
| Nov 5 | Benchmark | Upgrade | Hold → Buy | — | $7.85 | $9.32 | +18.7% | +0.0% | -6.4% | +2.0% | +3.8% | -2.0% |
| Oct 30 | Truist | Upgrade | Hold → Buy | — | $7.13 | $7.65 | +7.3% | +10.1% | +11.5% | +15.8% | +10.1% | +10.1% |
| Aug 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $6.74 | $6.80 | +0.9% | +4.9% | +2.7% | +0.1% | +1.8% | -3.1% |
| May 8 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $6.28 | $6.12 | -2.5% | -8.4% | +0.6% | -5.7% | -18.5% | -24.4% |
| Mar 26 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $8.16 | $8.09 | -0.9% | -8.8% | -24.3% | -22.4% | -17.4% | -11.3% |
| Nov 6 | BMO Capital | Maintains | Market Perform → Market Perform | — | $11.35 | $12.39 | +9.2% | +9.0% | +9.5% | +11.5% | +9.7% | +10.1% |
No insider trades available.
8-K · 1.01
!!! Very High
Cross Country Healthcare, Inc. -- 8-K 1.01: Merger Agreement
Cross Country Healthcare agreed to merge, creating potential shareholder value through a strategic combination that will be determined by the final transaction terms and regulatory approval.
May 7
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on April 17, 2026, disclosing material information to investors under Regulation FD guidelines.
Apr 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CCRN's departure of an executive officer removes potential relationship conflicts but raises questions about leadership stability and operational continuity that investors should monitor.
Mar 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The company's technology officer departure signals potential instability in critical infrastructure management, which could delay digital initiatives and warrant scrutiny of replacement candidate qualifications.
Mar 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Leadership transition effective March 10, 2026 could signal strategic direction changes or internal instability, making stock performance dependent on successor credibility and market confidence in continuity.
Mar 10
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare disclosed material information to investors under Regulation FD, ensuring equal access to non-public details across all shareholders simultaneously.
Mar 4
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on February 23, 2026, with details available in the filing exhibit, though the specific announcement content requires reviewing the attached materials for investment impact assessment.
Feb 23
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on February 12, 2026, disclosing material information to investors through regulatory filing.
Feb 12
Data updated apr 25, 2026 12:25am
· Source: massive.com